ID18447A - Penggunaan bahan bahan antagonis bradykinin nonpeptida untuk pengobatan dan pencegahan gangguan hati fibrogenetik kronis gangguan hati akut dan komplikasi yang berhubungan denganya - Google Patents

Penggunaan bahan bahan antagonis bradykinin nonpeptida untuk pengobatan dan pencegahan gangguan hati fibrogenetik kronis gangguan hati akut dan komplikasi yang berhubungan denganya

Info

Publication number
ID18447A
ID18447A IDP971698A ID971698A ID18447A ID 18447 A ID18447 A ID 18447A ID P971698 A IDP971698 A ID P971698A ID 971698 A ID971698 A ID 971698A ID 18447 A ID18447 A ID 18447A
Authority
ID
Indonesia
Prior art keywords
heart disorders
fibrogenetic
nonpeptid
antagonic
bradykinin
Prior art date
Application number
IDP971698A
Other languages
English (en)
Indonesian (id)
Inventor
Holger Heitsch
Adalbert Wagner
Klaus Wirth
Max Hropot
Martin Bickel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996120509 external-priority patent/DE19620509A1/de
Priority claimed from DE19632042A external-priority patent/DE19632042A1/de
Priority claimed from DE19639303A external-priority patent/DE19639303A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ID18447A publication Critical patent/ID18447A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDP971698A 1996-05-22 1997-05-21 Penggunaan bahan bahan antagonis bradykinin nonpeptida untuk pengobatan dan pencegahan gangguan hati fibrogenetik kronis gangguan hati akut dan komplikasi yang berhubungan denganya ID18447A (id)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE1996120509 DE19620509A1 (de) 1996-05-22 1996-05-22 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19632042A DE19632042A1 (de) 1996-08-08 1996-08-08 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
DE19639303A DE19639303A1 (de) 1996-09-25 1996-09-25 Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen
US08/858,550 US5786365A (en) 1996-05-22 1997-05-19 Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith

Publications (1)

Publication Number Publication Date
ID18447A true ID18447A (id) 1998-04-09

Family

ID=27438369

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971698A ID18447A (id) 1996-05-22 1997-05-21 Penggunaan bahan bahan antagonis bradykinin nonpeptida untuk pengobatan dan pencegahan gangguan hati fibrogenetik kronis gangguan hati akut dan komplikasi yang berhubungan denganya

Country Status (23)

Country Link
US (1) US5786365A (ja)
EP (2) EP0808627A2 (ja)
JP (1) JP4034849B2 (ja)
CN (1) CN1176102A (ja)
AT (1) ATE189389T1 (ja)
AU (1) AU2351197A (ja)
BR (1) BR9703367A (ja)
CA (1) CA2205780A1 (ja)
CZ (1) CZ154697A3 (ja)
DE (1) DE59701078D1 (ja)
DK (1) DK0808628T3 (ja)
ES (1) ES2144291T3 (ja)
GR (1) GR3033048T3 (ja)
HR (1) HRP970278A2 (ja)
HU (1) HUP9700913A1 (ja)
ID (1) ID18447A (ja)
IL (1) IL120862A0 (ja)
NO (1) NO972311L (ja)
PL (1) PL320134A1 (ja)
PT (1) PT808628E (ja)
SI (1) SI0808628T1 (ja)
SK (1) SK63097A3 (ja)
TR (1) TR199700392A2 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
US6767889B1 (en) 1998-11-10 2004-07-27 Temple University Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
WO2000027866A1 (en) * 1998-11-10 2000-05-18 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
ATE324901T1 (de) 1998-11-10 2006-06-15 Univ Temple Hemmung der angiogenese durch peptidanaloge der kininogen domäne 5mit hohem molekulargewicht
US6869931B1 (en) 1998-12-16 2005-03-22 Temple University - Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
US6994852B1 (en) 1999-11-12 2006-02-07 Temple University-Of The Commonwealth System Of Higher Education Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5
US6445588B1 (en) 2001-01-02 2002-09-03 Motorola, Inc. Apparatus and method for securing a printed circuit board to a base plate
BRPI0417543A (pt) 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
AU2006228957A1 (en) * 2005-04-01 2006-10-05 Methylgene Inc. Inhibitors of histone deacetylase
US10517765B2 (en) 2010-06-29 2019-12-31 Jennifer DiGrazia Wound and bandage protection system and method
AU2011276482A1 (en) * 2010-06-29 2013-02-21 Jennifer Digrazia Wound and bandage protection system and method
RU2514345C1 (ru) * 2012-10-09 2014-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования степени риска геморрагических осложнений при миниинвазивных хирургических вмешательствах на печени

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP3049648B2 (ja) * 1993-12-13 2000-06-05 日立金属株式会社 加圧成形方法および加圧成形機
WO1996004251A1 (fr) * 1994-08-03 1996-02-15 Fujisawa Pharmaceutical Co., Ltd. Compose heterocyclique

Also Published As

Publication number Publication date
ATE189389T1 (de) 2000-02-15
AU2351197A (en) 1997-11-27
HRP970278A2 (en) 1998-04-30
CA2205780A1 (en) 1997-11-22
HU9700913D0 (en) 1997-07-28
IL120862A0 (en) 1997-09-30
US5786365A (en) 1998-07-28
NO972311D0 (no) 1997-05-21
CZ154697A3 (en) 1997-12-17
EP0808628B1 (de) 2000-02-02
BR9703367A (pt) 1998-09-15
TR199700392A2 (xx) 1997-12-21
SI0808628T1 (en) 2000-04-30
CN1176102A (zh) 1998-03-18
JP4034849B2 (ja) 2008-01-16
PL320134A1 (en) 1997-11-24
MX9703725A (es) 1997-11-29
EP0808628A3 (de) 1998-01-14
HUP9700913A1 (hu) 1999-09-28
EP0808628A2 (de) 1997-11-26
ES2144291T3 (es) 2000-06-01
SK63097A3 (en) 1997-12-10
NO972311L (no) 1997-11-24
EP0808627A2 (de) 1997-11-26
DE59701078D1 (de) 2000-03-09
JPH1045624A (ja) 1998-02-17
DK0808628T3 (da) 2000-06-26
GR3033048T3 (en) 2000-08-31
PT808628E (pt) 2000-05-31

Similar Documents

Publication Publication Date Title
ID18447A (id) Penggunaan bahan bahan antagonis bradykinin nonpeptida untuk pengobatan dan pencegahan gangguan hati fibrogenetik kronis gangguan hati akut dan komplikasi yang berhubungan denganya
LU91417I2 (fr) "Maraviroc, optionnellement sous forme d'un sel pharmaceutiquement acceptable CELSENTRI"
PT863136E (pt) Derivados de azetidina e de pirrolidina
HUP0000487A2 (hu) Neurokinin antagonistaként alkalmazható szubsztituált oximszármazékok
DE69132713D1 (de) Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren
GB2210366B (en) Substituted cycloalkanols
FI935360A0 (fi) Guanidinalkyl-1,1-bifosfonsyraderivat, foerfarande foer deras framstaellning samt deras anvaendning
ATE284692T1 (de) Verwendung von nicht-peptidischen bradykinin- antagonisten zur herstellung von arzneimitteln zur behandlung und prävention der alzheimerischen krankheit
NO20001515L (no) Vitronektin reseptor-antagonist
DE69925270D1 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
BR0008321A (pt) Secretagogos de hormÈnio de crescimento
DK0838223T3 (da) Hjerneødeminhibitor
ATE97810T1 (de) Injizierbare cephalosporinpraeparate und ihre anwendung.
OA09027A (fr) Procédé d'inhibition. d'un virus
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
NO975903D0 (no) N-benzylpiperazin-forbindelser, fremgangsmåte ved fremstilling derav, samt farmasöytiske blandinger
PL319193A1 (en) Application of bradikinin antagonists for obtaining a pharmaceutic agent, method of obtaining same and pharmaceutic agent as such
DE69214586D1 (de) Methanoanthracene als Dopaminantagonisten
ATE250027T1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE69916577D1 (de) Azetidincarboxamid-derivate zur behandlung von zns störungen
PL329885A1 (en) Derivatives of polyhydroxyphenol and agents containing them for use in prophylactics and treatment of bone and cartilage diseases
FR2796274B1 (fr) Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
AP2002002665A0 (en) Antihypertensive agents and use.
TH14699A (th) สารต้านฤทธิ์แอนจิโอเทนซิน ii
CO4970784A1 (es) Antagonistas del receptor de fibrinogen